All News

 
Press Release – PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program

PrimeVigilance is pleased to share ERGOMED plc Press Release and to part of front against coronavirus

Published
30 March 2020.

Read more
 
NEWS – PrimeVigilance response to Zagreb earthquake

Our united front: PrimeVigilance response to Zagreb earthquake

Published
23 March 2020.

Read more
 
NEWS – A Message from Ergomed plc Executive Chairman Dr Miroslav Reljanovic : Ergomed Response to COVID-19

Our United Front : Ergomed Plc Response to COVID-19 

Published
21 March 2020.

Read more
 
PRESS RELEASE – Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study

Guildford, UK – 18 March 2020: Ergomed plc (LSE: ERGO) (‘Ergomed’ or the ‘Company’), a company focused on providing specialised services to the pharmaceutical industry, today announces the initiation of a study of siltuximab, an interleukin (IL)-6 targeted monoclonal antibody, for the treatment of patients with COVID-19 who have developed serious respiratory complications (Siltuximab In Serious COVID-19; SISCO Study). The study is sponsored by the Papa Giovanni XXIII Hospital in Bergamo, Italy and supported by EUSA Pharma (EUSA) (see announcement below).

Published
18 March 2020.

Read more
 
Press Release – PrimeVigilance Acquires Ashfield Pharmacovigilance Inc.

PrimeVigilance is delighted to share the exciting news about an investment PrimeVigilance, part of Ergomed plc. has made in order to significantly expand our expert service supporting all products in major pharmaceutical markets around the world.

Published
13 January 2020.

Read more
 
News – 3rd ISoP Seminar on Intelligent Automation in Pharmacovigilance chaired by Dr. Jan Petracek

PrimeVigilance, an Ergomed company is pleased to promote the upcoming unique and highly focused ISoP two-days seminar, that will explore process automation and AI in the Pharmacovigilance Lifecycle, The topic will be debated by a team of specialists, chaired by Dr Jan Petracek, PrimeVigilance Strategic Advisor and an ISoP Board member.

Published
14 November 2019.

Read more

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.